Our new platform for rapid antibiotic susceptibility testing (AST), the MelodyOne, reads testpanels containing our patented graphene nanomotion chips. Positive samples can be tested for resistance within one hour.
Our technology is based on graphene membrane sensors that are sensitive enough to measure the nanomotion from single bacterial cells. The amplitude of the nanomotion signal tells us if the cells stay alive or die in the presence of antibiotics.
The MelodyOne supports a broad range of pathogens (gram-positive/negative) and drugs, requires no markers, relies purely on phenotypic viability, can perform direct testing of unamplified patient samples, and provides results within 1 hour.
